ISHARA INVESTMENTS
Biotechnology is a volatile and non-deterministic domain riddled with uncertainty.
We leverage data science, scientific knowledge, and a human understanding to make accurate predictions. Further, our risk controls limit the impact of adverse outcomes on our strategy.
How We Invest
Our Founder
Our Founder, Shaun Mehra, is an alumni of Citadel Global Equities, Silver Lake Partners, and other global multi-billion dollar public and private investment funds.
Mehra holds a BSE in biomedical engineering from the University of Pennsylvania and a BSE in management entrepreneurship from the Wharton School.
For more information, please reach out to:
shaun@isharainvestments.com
ISHARA INVESTMENTS
Biotech-focused investment advisor
Located in San Francisco, CA
Financial District
Invest with Intent
Biotechnology-focused investment advisor
Founded in 2023 by Shaun Mehra
About Us
Ishara means 'signal' or 'clue,' the primary input for our proprietary investment process.
We invest in differentiated and underappreciated public biotechnology companies pursuing the clinical, regulatory, and commercial advancement of medical drugs for patients in need.
We employ a low-net exposure strategy and have expertise across therapeutic areas.
